×
Customize
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Understanding PARP Inhibition in BRCA-Mutated Breast Cancer
Joyce A. O’Shaughnessy, MD, considers the potential of PARP inhibition to improve outcomes in the setting of BRCA-positive breast cancer.
Episode 1 Appropriately Diagnosing and Classifying Breast Cancer
Joyce A. O’Shaughnessy, M.D., taps into her extensive experience to provide a brief overview of breast cancer presentation, diagnosis and classification.
Episode 2 Considering Treatment for HER2-Negative Breast Cancer
Episode 3 BRCA Mutations in HER2-Negative Breast Cancer
Episode 4 BRCA+ Breast Cancer: The Advent of PARP Inhibitors
Episode 5 Future Role of PARP Inhibition in BRCA+ Breast Cancer
Episode 6 Breaking Down the Nature of Breast Cancer
Episode 7 Breast Cancer Diagnosis: Addressing Questions and Concerns
Episode 8 Treatment Options for HER2-Negative Breast Cancer
Episode 9 Benefit of PARP Inhibitors in BRCA+ Breast Cancer
Episode 10 BRCA+ Breast Cancer: Managing Patients on PARP Inhibitors
Episode 11 Multidisciplinary Management of Breast Cancer
Episode 12 Future Treatment Options for BRCA+ Breast Cancer